Status:
UNKNOWN
Investigating Atherosclerosis In Seronegative Spondyloarthropathy
Lead Sponsor:
Sohag University
Conditions:
In Seronegative Spondyloarthropathy
Eligibility:
All Genders
16+ years
Brief Summary
The association between inflammation and atherosclerosis is widely known. An increase in morbidity and mortality due to cardiovascular (CV) disease in inflammatory rheumatic diseases has been proved \...
Detailed Description
The association between inflammation and atherosclerosis is widely known. An increase in morbidity and mortality due to cardiovascular (CV) disease in inflammatory rheumatic diseases has been proved ....
Eligibility Criteria
Inclusion
- Age at disease onset above 16 yrs old
- Patients diagnosed as according to 1984 modified New York criteria of AS .including radiographic and non-radiographic AS according to ASAS crteriae\[22\].
- Psoriatic arthritis patients fulfilling the diagnostic criteria defined by the Classification Criteria of Psoriatic Arthritis (CASPAR\[23\]study and with a diagnosis confirmed by a rheumatologist
Exclusion
- Diabetes mellitus or use of antidiabetic medication.
- Heart failure, as defined by ejection fraction \<50%.
- Renal disease.
- Chronic obstructive lung disease; pulmonary hypertension; pregnancy or obesity.
- Metabolic syndrome.
- History of cardiovascular, peripheral artery disease, or cerebrovascular events.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04891783
Start Date
June 1 2021
End Date
June 30 2023
Last Update
May 21 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.